Go Symbol Lookup
Loading...

ECB Injects More Money Into Bank System

 Text Size  
Published: Monday, 13 Aug 2007 | 8:06 AM ET
By: AP

The European Central Bank on Monday injected another 47.67 billion euros ($65 billion) into the banking system in a bid to soothe rattled credit markets, but said that market conditions are "normalizing."

European shares were rebounding Monday after sharp declines last week on because of global worries about dubious U.S. mortgages. Earlier Monday, Japan's central bank said it injected 600 billion yen ($5 billion; 3.6 billion euros) into money markets.

The ECB's one-day quick tender Monday was smaller than its previous injections of funds to banks 95 billion euros ($130 billion) last Thursday and a further 61 billion euros ($83.6 billion) on Friday. Those moves were made in conjunction with similar efforts by other central banks.

Accompanying Monday's operation, in which the ECB received 59 bids worth a total of 84.45 billion euros ($115.6 billion) was a calming note.

"The ECB notes that money market conditions are normalizing and that the supply of aggregate liquidity is ample," the ECB said. "With this fine-tuning operation, the ECB is further supporting the normalization of conditions in the money market."

 Print
The European Central Bank on Monday injected another 47.67 billion euros ($65 billion) into the banking system in a bid to soothe rattled credit markets, but said that market conditions are "normalizing."

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

U.S. Video

  • Discussing the state of Detroit's economy, with CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum.

  • Larry Kudlow discusses the journalistic merit of a Financial Times article, which triggered a brief sell-off in U.S markets. Larry McDonald, Newedge; Ed Butowsky, Chapwood Investments; and Ron Kruszewski, Stifel Nicolaus join in the discussion later.

  • The Supreme Court ruled today that the FTC can keep challenging "pay to delay" deals between pharmaceutical companies and generic drugmakers. CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum, discuss.